|
CHEMBL230
|
P35354
|
Cyclooxygenase-2 |
99.77%
|
89.63%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.75%
|
98.95%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
97.97%
|
96.09%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
97.81%
|
98.33%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
97.54%
|
99.35%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
97.18%
|
94.66%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
96.53%
|
98.10%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
96.44%
|
96.03%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
96.34%
|
93.10%
|
|
CHEMBL221
|
P23219
|
Cyclooxygenase-1 |
95.81%
|
90.17%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
95.81%
|
100.00%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
95.78%
|
98.89%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
95.16%
|
92.38%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
94.85%
|
96.67%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
94.83%
|
98.24%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
94.61%
|
96.47%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
94.22%
|
97.09%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
94.09%
|
97.50%
|
|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
93.64%
|
97.25%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
93.46%
|
96.61%
|
|
CHEMBL204
|
P00734
|
Thrombin |
93.45%
|
96.01%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
93.14%
|
93.56%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
92.76%
|
99.77%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
92.40%
|
100.00%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
92.36%
|
95.71%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
91.75%
|
94.00%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
91.36%
|
90.71%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
91.24%
|
95.36%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
90.87%
|
98.94%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
90.51%
|
91.19%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
90.38%
|
97.64%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
90.11%
|
94.45%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
90.05%
|
97.47%
|
|
CHEMBL4208
|
P20618
|
Proteasome component C5 |
89.88%
|
90.00%
|
|
CHEMBL274
|
P51681
|
C-C chemokine receptor type 5 |
88.89%
|
98.77%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
88.54%
|
97.14%
|
|
CHEMBL5261
|
Q7L7X3
|
Serine/threonine-protein kinase TAO1 |
88.28%
|
89.33%
|
|
CHEMBL5701
|
Q9H2K8
|
Serine/threonine-protein kinase TAO3 |
88.26%
|
96.67%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
88.17%
|
97.29%
|
|
CHEMBL3892
|
Q99500
|
Sphingosine 1-phosphate receptor Edg-3 |
87.59%
|
97.29%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
87.21%
|
90.08%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
86.88%
|
94.33%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
86.49%
|
93.00%
|
|
CHEMBL4073
|
P09237
|
Matrix metalloproteinase 7 |
86.32%
|
97.56%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
86.02%
|
100.00%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
85.94%
|
96.85%
|
|
CHEMBL2094135
|
Q96BI3
|
Gamma-secretase |
85.94%
|
98.05%
|
|
CHEMBL2492
|
P36544
|
Neuronal acetylcholine receptor protein alpha-7 subunit |
85.68%
|
88.42%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
85.18%
|
95.38%
|
|
CHEMBL1873
|
P00750
|
Tissue-type plasminogen activator |
84.85%
|
93.33%
|
|
CHEMBL4361
|
Q07820
|
Induced myeloid leukemia cell differentiation protein Mcl-1 |
84.62%
|
95.52%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
84.23%
|
95.27%
|
|
CHEMBL5619
|
P27695
|
DNA-(apurinic or apyrimidinic site) lyase |
84.20%
|
91.11%
|
|
CHEMBL332
|
P03956
|
Matrix metalloproteinase-1 |
84.17%
|
94.50%
|
|
CHEMBL3468
|
P55210
|
Caspase-7 |
83.99%
|
95.68%
|
|
CHEMBL4203
|
Q9HAZ1
|
Dual specificity protein kinase CLK4 |
83.85%
|
94.45%
|
|
CHEMBL4461
|
Q9NTG7
|
NAD-dependent deacetylase sirtuin 3 |
83.30%
|
94.36%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
83.13%
|
96.67%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
82.85%
|
95.00%
|
|
CHEMBL3691
|
Q13822
|
Autotaxin |
82.24%
|
96.39%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
82.16%
|
100.00%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
82.08%
|
97.50%
|
|
CHEMBL2781
|
P19634
|
Sodium/hydrogen exchanger 1 |
81.93%
|
90.24%
|
|
CHEMBL4198
|
P98170
|
Inhibitor of apoptosis protein 3 |
81.61%
|
97.79%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
81.48%
|
97.43%
|
|
CHEMBL3976
|
Q9UHL4
|
Dipeptidyl peptidase II |
81.39%
|
92.29%
|
|
CHEMBL4793
|
Q86TI2
|
Dipeptidyl peptidase IX |
81.08%
|
96.95%
|
|
CHEMBL3476
|
O15111
|
Inhibitor of nuclear factor kappa B kinase alpha subunit |
81.01%
|
95.83%
|
|
CHEMBL4657
|
Q6V1X1
|
Dipeptidyl peptidase VIII |
80.94%
|
97.21%
|
|
CHEMBL233
|
P35372
|
Mu opioid receptor |
80.90%
|
97.93%
|
|
CHEMBL2083
|
P15090
|
Fatty acid binding protein adipocyte |
80.84%
|
95.71%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
80.54%
|
97.50%
|
|
CHEMBL2095194
|
P08709
|
Coagulation factor VII/tissue factor |
80.54%
|
99.17%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
80.33%
|
95.50%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
80.17%
|
95.89%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
80.01%
|
91.81%
|